Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404JF | ISIN: US8964385046 | Ticker-Symbol: TRB
Lang & Schwarz
24.04.25
07:00 Uhr
0,460 Euro
-0,460
-100,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRINITY BIOTECH PLC ADR Chart 1 Jahr
5-Tage-Chart
TRINITY BIOTECH PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
0,4600,46024.04.

Aktuelle News zur TRINITY BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.04.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer5
21.03.Trinity Biotech files to sell 4.29M American Depositary Shares for holders6
14.03.Trinity Biotech receives Nasdaq non-compliance notice22
TRINITY BIOTECH Aktie jetzt für 0€ handeln
14.03.Trinity Biotech plc: Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement191DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
13.03.Trinity Biotech plc: Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring - Appoints Barclays to Advise on Ongoing Strategic Realignment Process151DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions...
► Artikel lesen
13.03.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer5
28.02.Trinity Biotech sichert sich 4 Millionen US-Dollar für CGM-Technologie-Wachstum5
28.02.Trinity Biotech secures $4m for CGM technology growth2
28.02.Trinity Biotech plc: Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology152DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
► Artikel lesen
28.02.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer-
06.02.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer-
06.02.Trinity Biotech reports leap in CGM system accuracy2
06.02.Trinity Biotech vermeldet Durchbruch in der Genauigkeit des CGM-Systems5
06.02.Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial202DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
28.01.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer1
28.01.Trinity Biotech verkündet Durchbruch in CGM-Technologie16
28.01.Trinity Biotech announces breakthrough in CGM technology3
28.01.Trinity Biotech plc: Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology190DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
► Artikel lesen
27.12.24TRINITY BIOTECH PLC - 6-K, Report of foreign issuer12
24.12.24Trinity Biotech plc: Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan1.048DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1